
Marianne P. Allen
Examiner (ID: 17617, Phone: (571)272-0712 , Office: P/1647 )
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1818, 1812, 1645, 1805, 1631, 1647 |
| Total Applications | 2168 |
| Issued Applications | 1046 |
| Pending Applications | 251 |
| Abandoned Applications | 885 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8197114
[patent_doc_number] => 20120121626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-17
[patent_title] => 'Chimeric VEGF Peptides'
[patent_app_type] => utility
[patent_app_number] => 13/331891
[patent_app_country] => US
[patent_app_date] => 2011-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 13609
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20120121626.pdf
[firstpage_image] =>[orig_patent_app_number] => 13331891
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/331891 | Chimeric VEGF Peptides | Dec 19, 2011 | Abandoned |
Array
(
[id] => 8277350
[patent_doc_number] => 20120171217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-05
[patent_title] => 'Monoclonal Antibodies Against ANGPTL4'
[patent_app_type] => utility
[patent_app_number] => 13/315027
[patent_app_country] => US
[patent_app_date] => 2011-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 35424
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13315027
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/315027 | Monoclonal antibodies against ANGPTL4 | Dec 7, 2011 | Issued |
Array
(
[id] => 8854138
[patent_doc_number] => 20130143813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-06
[patent_title] => 'METHODS AND COMPOSITIONS FOR MODULATING HGF/MET'
[patent_app_type] => utility
[patent_app_number] => 13/313983
[patent_app_country] => US
[patent_app_date] => 2011-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 33558
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13313983
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/313983 | METHODS AND COMPOSITIONS FOR MODULATING HGF/MET | Dec 6, 2011 | Abandoned |
Array
(
[id] => 8054061
[patent_doc_number] => 20120076764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'METHODS AND PHARMACEUTICAL COMPOSITIONS FOR HEALING WOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/311675
[patent_app_country] => US
[patent_app_date] => 2011-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 23466
[patent_no_of_claims] => 111
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20120076764.pdf
[firstpage_image] =>[orig_patent_app_number] => 13311675
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/311675 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR HEALING WOUNDS | Dec 5, 2011 | Abandoned |
Array
(
[id] => 8239862
[patent_doc_number] => 20120148601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-14
[patent_title] => 'BACTERIAL SUPERANTIGEN VACCINES'
[patent_app_type] => utility
[patent_app_number] => 13/304835
[patent_app_country] => US
[patent_app_date] => 2011-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17744
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13304835
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/304835 | Bacterial superantigen vaccines | Nov 27, 2011 | Issued |
Array
(
[id] => 10549495
[patent_doc_number] => 09274115
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-01
[patent_title] => 'Anti-IL-6 antibodies for the treatment of anemia'
[patent_app_type] => utility
[patent_app_number] => 13/304233
[patent_app_country] => US
[patent_app_date] => 2011-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 39
[patent_no_of_words] => 101479
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13304233
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/304233 | Anti-IL-6 antibodies for the treatment of anemia | Nov 22, 2011 | Issued |
Array
(
[id] => 10549495
[patent_doc_number] => 09274115
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-01
[patent_title] => 'Anti-IL-6 antibodies for the treatment of anemia'
[patent_app_type] => utility
[patent_app_number] => 13/304233
[patent_app_country] => US
[patent_app_date] => 2011-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 39
[patent_no_of_words] => 101479
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13304233
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/304233 | Anti-IL-6 antibodies for the treatment of anemia | Nov 22, 2011 | Issued |
Array
(
[id] => 10549495
[patent_doc_number] => 09274115
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-01
[patent_title] => 'Anti-IL-6 antibodies for the treatment of anemia'
[patent_app_type] => utility
[patent_app_number] => 13/304233
[patent_app_country] => US
[patent_app_date] => 2011-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 39
[patent_no_of_words] => 101479
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13304233
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/304233 | Anti-IL-6 antibodies for the treatment of anemia | Nov 22, 2011 | Issued |
Array
(
[id] => 9033829
[patent_doc_number] => 20130236467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-12
[patent_title] => 'MULTISPECIFIC ANTIGEN BINDING PROTEINS TARGETING HGF'
[patent_app_type] => utility
[patent_app_number] => 13/988375
[patent_app_country] => US
[patent_app_date] => 2011-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 41871
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13988375
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/988375 | MULTISPECIFIC ANTIGEN BINDING PROTEINS TARGETING HGF | Nov 22, 2011 | Abandoned |
Array
(
[id] => 10549495
[patent_doc_number] => 09274115
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-01
[patent_title] => 'Anti-IL-6 antibodies for the treatment of anemia'
[patent_app_type] => utility
[patent_app_number] => 13/304233
[patent_app_country] => US
[patent_app_date] => 2011-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 39
[patent_no_of_words] => 101479
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13304233
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/304233 | Anti-IL-6 antibodies for the treatment of anemia | Nov 22, 2011 | Issued |
Array
(
[id] => 9476717
[patent_doc_number] => 20140134181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-15
[patent_title] => 'Treatment Method For Lung Remodeling Diseases'
[patent_app_type] => utility
[patent_app_number] => 13/883521
[patent_app_country] => US
[patent_app_date] => 2011-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 18427
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13883521
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/883521 | Treatment Method For Lung Remodeling Diseases | Nov 6, 2011 | Abandoned |
Array
(
[id] => 8566484
[patent_doc_number] => 20120329055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-27
[patent_title] => 'USE OF ALPHA1G SUBUNIT OF T-TYPE CALCIUM CHANNEL AS DIAGNOSTIC MARKER FOR PREGNANCY IN CATTLE'
[patent_app_type] => utility
[patent_app_number] => 13/290894
[patent_app_country] => US
[patent_app_date] => 2011-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6956
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13290894
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/290894 | Use of α1G subunit of T-type calcium channel as diagnostic marker for pregnancy in cattle | Nov 6, 2011 | Issued |
Array
(
[id] => 8187173
[patent_doc_number] => 20120116062
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'TECHNOLOGY FOR PREPARATION OF MACROMOLECULAR MICROSPHERES'
[patent_app_type] => utility
[patent_app_number] => 13/289644
[patent_app_country] => US
[patent_app_date] => 2011-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36536
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20120116062.pdf
[firstpage_image] =>[orig_patent_app_number] => 13289644
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/289644 | Technology for preparation of macromolecular microspheres | Nov 3, 2011 | Issued |
Array
(
[id] => 9937152
[patent_doc_number] => 08986956
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-24
[patent_title] => 'Method for producing human epidermal growth factor in large volume from yeast'
[patent_app_type] => utility
[patent_app_number] => 13/883264
[patent_app_country] => US
[patent_app_date] => 2011-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6979
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13883264
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/883264 | Method for producing human epidermal growth factor in large volume from yeast | Nov 3, 2011 | Issued |
Array
(
[id] => 8240900
[patent_doc_number] => 20120149642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-14
[patent_title] => 'FIBROSIS INHIBITOR FOR IMPLANTED ORGAN'
[patent_app_type] => utility
[patent_app_number] => 13/288392
[patent_app_country] => US
[patent_app_date] => 2011-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8580
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13288392
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/288392 | Fibrosis inhibitor for implanted organ | Nov 2, 2011 | Issued |
Array
(
[id] => 8239875
[patent_doc_number] => 20120148607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-14
[patent_title] => 'ANTI C-MET ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 13/288566
[patent_app_country] => US
[patent_app_date] => 2011-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 44281
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13288566
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/288566 | Anti c-Met antibodies | Nov 2, 2011 | Issued |
Array
(
[id] => 7776289
[patent_doc_number] => 20120039882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => 'Vascular Disease Therapies'
[patent_app_type] => utility
[patent_app_number] => 13/279086
[patent_app_country] => US
[patent_app_date] => 2011-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 13778
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20120039882.pdf
[firstpage_image] =>[orig_patent_app_number] => 13279086
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/279086 | Vascular Disease Therapies | Oct 20, 2011 | Abandoned |
Array
(
[id] => 8228711
[patent_doc_number] => 20120142900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-07
[patent_title] => 'ANTIBODIES TO IL-6 AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/277390
[patent_app_country] => US
[patent_app_date] => 2011-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 82250
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13277390
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/277390 | ANTIBODIES TO IL-6 AND USE THEREOF | Oct 19, 2011 | Abandoned |
Array
(
[id] => 9126627
[patent_doc_number] => 08574573
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-05
[patent_title] => 'Anti-IL12Rbeta1 antibodies and their use in treating autoimmune and inflammatory disorders'
[patent_app_type] => utility
[patent_app_number] => 13/252721
[patent_app_country] => US
[patent_app_date] => 2011-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37360
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13252721
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/252721 | Anti-IL12Rbeta1 antibodies and their use in treating autoimmune and inflammatory disorders | Oct 3, 2011 | Issued |
Array
(
[id] => 9318433
[patent_doc_number] => 20140050771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-20
[patent_title] => 'PDGF INDUCED CELL HOMING'
[patent_app_type] => utility
[patent_app_number] => 13/877272
[patent_app_country] => US
[patent_app_date] => 2011-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8480
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13877272
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/877272 | PDGF induced cell homing | Oct 2, 2011 | Issued |